US Patent

US8568793 — Sodium nitrite-containing pharmaceutical compositions

Composition of Matter · Assigned to Hope Medical Enterprises Inc · Expires 2031-12-24 · 6y remaining

Vulnerability score 15/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects pharmaceutical compositions containing sodium nitrite, methods for determining its purity, producing it, and using it for treatment.

USPTO Abstract

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Drugs covered by this patent

Patent Metadata

Patent number
US8568793
Jurisdiction
US
Classification
Composition of Matter
Expires
2031-12-24
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Hope Medical Enterprises Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.